1,200 articles
Peyton Rous
Francis Peyton Rous was an American cancer virologist who discovered the first tumor-inducing virus, Rous sarcoma virus, in chickens in 1911, winning the 1966 Nobel Prize 55 years later.
Phil Gold
Phil Gold, born in Montreal in 1936, is a Canadian physician-scientist who co-discovered the tumor marker CEA in 1965, the basis of a widely used cancer blood test.
Philip A. Pizzo
Philip A. Pizzo, also known as Philip Pizzo, is an American pediatric oncologist known for defining fever management in children with cancer and for leading Stanford's medical school.
Philip J. Fialkow
Philip J. Fialkow (1934–1996) was an American physician-scientist and hematologist at the University of Washington who first showed that leukemia is a clonal stem-cell disease, and later served as the medical school's dean.
Philip Jones (cancer researcher)
Philip H. Jones is a British clinician-scientist who studies the earliest stages of cancer, and a Cambridge professor and Sanger Institute group leader elected a Fellow of the Royal Society in 2023.
Philip Rubin
Philip Rubin (1927–2014) was an American radiation oncologist who built the University of Rochester's radiation oncology department and became an international authority on late radiation effects on normal tissue.
Philip S. Schein
Philip S. Schein is a medical oncologist and pharmacologist who held senior posts at the National Cancer Institute and Georgetown, founded U.S. Bioscience, and served as president of ASCO.
Philip W. Hinds
Philip W. Hinds is an American cancer biologist at Tufts University School of Medicine in Boston who studies how pRB and D-type cyclins control the cell cycle.
Philip W. Kantoff
Philip W. Kantoff is an American medical oncologist who led genitourinary oncology at Dana-Farber for 28 years, then chaired medicine at Memorial Sloan Kettering from 2015.
Philipp Harter
Philipp Harter is a German gynecologic oncologist, director of gynecology and gynecologic oncology at Evang. Kliniken Essen-Mitte in Essen and speaker of the AGO study group.
Philippe Armand
Philippe Armand is a French-American? No—Philippe Armand is a physician-scientist and Chief of the Division of Lymphoma at Dana-Farber Cancer Institute, and Professor of Medicine at Harvard Medical School.
Philippe Morice
Philippe Morice is a French gynecological oncology surgeon at Gustave Roussy in Villejuif, known for fertility preservation and conservative surgery in ovarian and cervical cancer.
Pier Paolo Pandolfi
Pier Paolo Pandolfi is an Italian-born cancer geneticist, born in Rome, known for his work on the tumor suppressors PTEN and PML and on acute promyelocytic leukemia.
PierFranco Conte
PierFranco Conte is an Italian medical oncologist and full professor at the University of Padova, known for the OlympiAD olaparib trial in BRCA-mutated breast cancer.
Pierre Laurent‐Puig
Pierre Laurent-Puig is a French professor of oncology at Université Paris Cité who showed that KRAS mutations predict resistance to cetuximab in colorectal cancer and pioneered liquid-biopsy RAS testing.
Pinuccia Valagussa
Pinuccia Valagussa (died 2024) was an Italian oncology researcher and statistician at the Istituto Nazionale dei Tumori in Milan who co-designed the landmark CMF breast cancer trials.
Piotr Sicinski
Piotr Sicinski, also known as Piotr Siciński, is a Polish-born cancer biologist at Harvard Medical School and Dana-Farber whose cyclin knockout mice helped set the stage for CDK4/6 inhibitor cancer drugs.
Poul H. Sorensen
Poul H. Sorensen is a Danish-born physician-scientist and pathologist at the University of British Columbia whose lab discovered cancer gene fusions, including NTRK fusions, in childhood cancers.
Priscilla K. Brastianos
Priscilla K. Brastianos is a neuro-oncologist and physician-scientist who directs the Central Nervous System Metastasis Program at Massachusetts General Hospital and is Professor of Medicine at Harvard Medical School.
Prudence A. Francis
Prudence A. Francis, known as Prue Francis, is an Australian medical oncologist specializing in breast cancer, Clinical Co-Lead of Breast Medical Oncology at the Peter MacCallum Cancer Centre in Melbourne.
Qiang Yu
Qiang Yu is a Singapore-based cancer biologist who leads the Laboratory of Precision Cancer Medicine at A*STAR's Genome Institute of Singapore, known for discovering DZNep.
Qing Yi
Qing Yi is a Chinese-born American medical immunologist who identified tumor-eradicating Th9 cells and leads translational myeloma immunotherapy research as a chaired professor at Houston Methodist since 2018.
Rachel J. Perry
Rachel J. Perry is a physiologist and cancer researcher at Yale School of Medicine, where she leads a laboratory studying exercise physiology, tumor metabolism, and immunometabolism.
Radiation Oncologists
Radiation oncologists, also called radiotherapists or therapeutic radiologists, are physicians trained to treat cancer with radiation. They lead a team of physicists and dosimetrists, practice fractionation developed in the 1920s, and number over 5,300 in the US.
Rafael Rosell
Rafael Rosell is a Spanish medical oncologist who has specialized in lung cancer since 1982 and led Europe's implementation of routine EGFR mutation testing for first-line treatment.
Raghu Kalluri
Raghu Kalluri is a cancer biologist known for work on exosomes and the tumor microenvironment who chaired cancer biology at MD Anderson before leading the UTMB Cancer Center in 2026.
Raju S. Kucherlapati
Raju S. Kucherlapati is an Indian-born American human geneticist, the Paul C. Cabot Professor of Genetics at Harvard Medical School since 2001 and a 2008 National Academy of Medicine member.
Rakesh K. Jain
Rakesh K. Jain is a tumor biologist at Harvard Medical School and Massachusetts General Hospital, known for the vascular normalization hypothesis and the 2013 National Medal of Science.
Ralph H. Hruban
Ralph H. Hruban is a Johns Hopkins pathologist who directs the Sol Goldman Pancreatic Cancer Research Center and characterized the precursor lesions of pancreatic cancer.
Ralph R. Weichselbaum
Ralph R. Weichselbaum is an American physician-scientist in radiation oncology who chairs radiation oncology at the University of Chicago and defined the oligometastasis stage of cancer spread.